Company Filing History:
1 out of 269 
1 out of 1 Years Active: 2025
Title: Mian Qin: Innovator in Immune Agonists
Introduction
Mian Qin is a notable inventor based in Guangdong, China. He has made significant contributions to the field of immunology through his innovative research and development of immune agonists. His work focuses on enhancing the immune response, which has important implications for therapeutic applications.
Latest Patents
Mian Qin holds 1 patent for his invention titled "Immune Agonists." This patent presents a novel series of small molecular immune agonists of Toll-like receptor, characterized by a specific structure represented by Formula I. The application details the use of these immune agonists for activating and amplifying immune cells and lymphocytes. Furthermore, it outlines their potential in preparing immunomodulatory drugs, immune anti-tumor small molecule drugs, and immune anti-tumor macromolecular drugs.
Career Highlights
Throughout his career, Mian Qin has worked with prominent institutions, including Shenzhen University and Shenzhen Conjugenix Pharmaceutical Technology Company Limited. His research has contributed to advancements in immunotherapy and drug development.
Collaborations
Mian Qin has collaborated with esteemed colleagues such as Guangyi Jin and Zhulin Wang. Their joint efforts have furthered the understanding and application of immune agonists in medical science.
Conclusion
Mian Qin's innovative work in the field of immune agonists showcases his dedication to advancing immunological research. His contributions have the potential to lead to significant breakthroughs in therapeutic applications for immune-related conditions.